Our study suggests that BMI1 and SOX2, two CSC-related transcription factors overexpressed in thyroid neoplasms, are regulated by the Shh pathway at a post-transcriptional and transcriptional level, respectively; and that targeting the Shh pathway could be a novel strategy for treating thyroid cancer. Here, BMI1 is linked to thyroid gland carcinoma.